Literature DB >> 1848971

Circadian and sleep-related endocrine rhythms in schizophrenia.

E Van Cauter1, P Linkowski, M Kerkhofs, P Hubain, M L'Hermite-Balériaux, R Leclercq, M Brasseur, G Copinschi, J Mendlewicz.   

Abstract

Plasma levels of prolactin, growth hormone, corticotropin, and cortisol were measured at 15-minute intervals for 24 hours in nine unmedicated male schizophrenic patients and in nine age-matched normal male subjects. Each study was preceded by 3 days of habituation to the laboratory environment. Sleep was polygraphically recorded. The circadian and pulsatile variations present in each hormonal profile were quantitatively characterized with the use of computer algorithms specifically designed for analyses of hormonal fluctuations. The major abnormality of neuroendocrine release that was observed in the schizophrenic patients was an almost threefold enhancement of the sleep-related increase in the prolactin level, associated with an intensified frequency of nocturnal prolactin pulses. This increased stimulatory effect of sleep on prolactin secretion was evident immediately after sleep onset. The normal inhibition of cortisol secretion during early sleep was absent in schizophrenic patients. The major sleep abnormalities were a prolonged sleep latency and a reduction in total rapid eye movement stage sleep. During wakefulness, prolactin and cortisol levels were normal. The 24-hour profile of growth hormone was unaltered in schizophrenic patients, and a sleep-onset growth hormone pulse was observed in all patients. No abnormalities were noted in the levels or temporal organization of corticotropin secretion. Both the amplitude and the timing of the cortisol rhythm were normal. We conclude that, in schizophrenic men, pituitary-adrenal function and circadian time-keeping are normal but prolactin secretion is hyperresponsive to the physiologic stimulus of sleep onset. Schizophrenia thus appears to be characterized by a subset of neuroendocrine disturbances distinct from that observed in major endogenous depression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848971     DOI: 10.1001/archpsyc.1991.01810280064009

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  22 in total

1.  Could stress cause psychosis in individuals vulnerable to schizophrenia?

Authors:  Cheryl Corcoran; Lilianne Mujica-Parodi; Scott Yale; David Leitman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

Review 2.  Sleep-dependent memory consolidation and its implications for psychiatry.

Authors:  Monique Goerke; Notger G Müller; Stefan Cohrs
Journal:  J Neural Transm (Vienna)       Date:  2015-10-30       Impact factor: 3.575

Review 3.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

4.  Sleep in patients with schizophrenia.

Authors:  Fabio Ferrarelli
Journal:  Curr Sleep Med Rep       Date:  2015-04-11

5.  Hormone profile in acute psychotic disorders: A cross-sectional comparison of serum hormone concentrations in treated and untreated male patients with schizophrenia.

Authors:  Anna Maria Niccolai Costa; Maurcio Silva de Lima; Juliana Tosta; Salomõ Rodrigues Filho; Irismar Reis de Oliveira; Eduardo Pondéde Sena; Jair de Jesus Mari
Journal:  Curr Ther Res Clin Exp       Date:  2006-09

Review 6.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

7.  Fast sleep spindle reduction in schizophrenia and healthy first-degree relatives: association with impaired cognitive function and potential intermediate phenotype.

Authors:  Claudia Schilling; Manuel Schlipf; Simone Spietzack; Franziska Rausch; Sarah Eisenacher; Susanne Englisch; Iris Reinhard; Leila Haller; Oliver Grimm; Michael Deuschle; Heike Tost; Mathias Zink; Andreas Meyer-Lindenberg; Michael Schredl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-26       Impact factor: 5.270

8.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

9.  Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Authors:  Dwight Dickinson; Philip D Harvey
Journal:  Schizophr Bull       Date:  2008-08-09       Impact factor: 9.306

Review 10.  Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia.

Authors:  Fabio Ferrarelli; Giulio Tononi
Journal:  Schizophr Res       Date:  2016-06-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.